These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8299241)
1. Bone marrow function during quadruple immunosuppressive therapy after renal transplantation. Heaf J Clin Nephrol; 1993 Dec; 40(6):332-8. PubMed ID: 8299241 [TBL] [Abstract][Full Text] [Related]
2. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients. Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176 [TBL] [Abstract][Full Text] [Related]
3. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients. Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659 [TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome. Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318 [TBL] [Abstract][Full Text] [Related]
6. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients. Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413 [TBL] [Abstract][Full Text] [Related]
7. A controlled trial antilymphocyte globulin therapy (ALG) in man. Sheil AG; Mears D; Kelly GE; Stewart JH; Johnson JR; Tiller D; Gallery ED; Duggin GG Transplant Proc; 1972 Dec; 4(4):501-5. PubMed ID: 4118965 [No Abstract] [Full Text] [Related]
8. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results. Schulz T; Kapischke M; Busing M Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475 [TBL] [Abstract][Full Text] [Related]
9. Quadruple immunosuppression in a pig model of small bowel transplantation. Gruessner RW; Fasola C; Fryer J; Nakhleh RE; Kim S; Gruessner AC; Beebe D; Moon C; Troppmann C; Najarian JS J Surg Res; 1996 Feb; 61(1):260-6. PubMed ID: 8769976 [TBL] [Abstract][Full Text] [Related]
10. Long-term renal function in heart transplant recipients receiving cyclosporine therapy. Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509 [TBL] [Abstract][Full Text] [Related]
11. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants. Lucan M; Iacob G; Lucan C; Lăpuşan C; Munteanu A; Sîrbu S Transplant Proc; 2004 Mar; 36(2 Suppl):177S-180S. PubMed ID: 15041332 [TBL] [Abstract][Full Text] [Related]
12. Quadruple induction immunosuppression after liver transplantation with interleukin-2 receptor antibody (BT 563) is equally effective and better tolerated than antithymocyte globulin induction therapy. Neuhaus P; Bechstein WO; Blumhardt G; Steffen R; Keck H; Lemmens P; Langrehr JM; Schlag H Transplant Proc; 1993 Apr; 25(2):1940-1. PubMed ID: 8470234 [No Abstract] [Full Text] [Related]
13. Prospective randomized comparison of quadruple vs triple therapy for first cadaver transplants with immediate function. Johnson CP; Slakey DP; Callaluce RD; Browne BJ; Roza AM; Adams MB Transplant Proc; 1993 Feb; 25(1 Pt 1):585-6. PubMed ID: 8438425 [No Abstract] [Full Text] [Related]
14. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy. Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP Clin Transpl; 1996; ():257-64. PubMed ID: 9286575 [TBL] [Abstract][Full Text] [Related]
15. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers. Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184 [TBL] [Abstract][Full Text] [Related]
16. [The clinical use of antilymphocyte globulin (ALG) (author's transl)]. Brendel W; Seifert J; Ring J MMW Munch Med Wochenschr; 1975 Aug; 117(35):1361-8. PubMed ID: 809676 [TBL] [Abstract][Full Text] [Related]
17. Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro. Knight SC; Lance EM; Abbosh J; Munro A; O'Brien J Clin Exp Immunol; 1975 Jul; 21(1):23-31. PubMed ID: 1181076 [TBL] [Abstract][Full Text] [Related]
18. Posttransplant serum creatinine area under the curve predicts renal allograft outcome. Sumrani N; Hong J; Miles A; Markell M; Distant D; Fleishhacker J; Maursky V; Jean-Baptiste F; Sommer B Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260 [No Abstract] [Full Text] [Related]
19. Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients. Cueto-Manzano AM; Konel S; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R; Hutchison AJ Transplantation; 2003 Jun; 75(12):2053-8. PubMed ID: 12829911 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effect of antithymocyte/antilymphocyte globulin on severe aplastic anemia and therapy-related complications]. Yu F; Tang SQ; Wang JW Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):479-81. PubMed ID: 17178040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]